希少疾患における偽結果試験からの広範な教訓
Laurent Servais1, Maryam Oskoui2
1Division of Child Neurology, Department of Pediatrics, Reference Center for Neuromuscular Diseases, CHU and University of Liege, Liege, Belgium; Oxford Neuromuscular Centre and National Institute for Health and Care Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 9DU, UK.
No abstract available in PubMed .
さらに関連する動画
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
関連する概念動画
Clinical Trials: Overview
Regression Toward the Mean
Treatment Resistant Cancers
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
